Medical Science Liaison

Company Overview

Protara Therapeutics is a clinical‑stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell‑based therapy in development for the treatment of non‑muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette‑Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs.

Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral support who are otherwise unable to meet their choline needs via oral or enteral routes.

Protara was named one of the Best Places to Work by Bio Space, a leading industry news and job source. This honor demonstrates the company’s desirability in the recruitment marketplace, looking at various merits with an emphasis on culture, career growth and development opportunities, leadership and innovation. Attracting and retaining top talent is integral to building a successful company in biotech, and we are committed to ensuring Protara provides our employees with an exceptional experience throughout their careers, even as we continue to grow.

As our Medical Science Liaison (MSL), you’ll be part of our field‑based medical team, reporting to the Director of Medical Science Liaisons. The rare disease/oncology focused MSL develops on‑going professional relationships with national and regional healthcare opinion leaders and other healthcare professionals in the hospital, institutional or clinical setting to provide medical and scientific support for company initiatives for TARA-002 (Lymphatic Malformations and NMIBC/oncology) and IV Choline Chloride.

• We have 4 Medical Science Liaison (MSL) roles open to cover Colorado, Florida, Texas, Georgia, and Arizona.

• Identify and engage with top hospital‑based clinicians and researchers to understand scientific needs and gather insights that support Protara strategies.
• Clinical Support:
  The MSL provides crucial, evidence‑based data, and shares up‑to‑date treatment guidelines with hospital staff.
• Develop and maintain scientific, clinical, and technical expertise in Protara’s rare disease and uro‑oncology portfolio through ongoing training and self‑education, including attendance at relevant conferences, scientific workshops, and review of key publications and resources.
• Build territory plans for assigned geographies to include strategies and tactics for engagement with HCPs/key opinion leaders (KOLs) at their respective institutions and medical congresses.
• Support clinical trial execution including recruitment and site outreach as requested and communicate feedback to the Clinical Operations and Clinical Development teams. Work collaboratively with Clinical Operations and Clinical Development teams as requested.
• Identify, establish, and maintain collaborative relationships with key investigators, institutional leaders, medical groups, and consortia.
• Provide scientific evidence and clinical trial information to healthcare professionals, clinical trial staff, and payors in a clear, scientifically accurate, and balanced manner.
• Increase awareness in the medical community of the company and enhance company interaction with thought leaders.
• Assist in training of new hire MSLs and, as appropriate. This includes assisting in design and implementation of effective training curricula and field resources that will promote the company’s reputation as a patient‑oriented and science‑driven organization; a reliable source of balanced medical information; and a partner in education and research with health care providers (HCPs) engaged in treating patients with rare and oncologic diseases.
• Support the development and implementation of advisory boards and other scientific meetings. Present scientific data at these forums as requested.
• Monitor the competitive landscape for…